SLC2A5 and cancer: Their studies have shown the feasibility of using these probes for high-throughput cancer identification and the potential development of a novel GLUT5-targeting glycoconjugate as a PET probe (Begoyan et al. 2018; Nahrjou et al. 2021; Oronova & Tanasova 2023) (Fig. 2).